Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial
-
Wysham, Carol (Rockwood Clinic (Spokane, Washington))
;
Bonadonna, Riccardo C (University of Parma) ;
Aroda, Vanita R. (Medstar Health Research Institute (Hyattsville, Maryland)) ;
Puig Domingo, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Kapitza, Christoph (Profil Institute (Neuss, Alemanya)) ;
Stager, William (Sanofi) ;
Yu, Christine (Sanofi) ;
Niemoeller, Elisabeth (Sanofi) ;
Souhami, Elisabeth (Sanofi) ;
Bergenstal, Richard M. (International Diabetes Center (Minneapolis, Estats Units)) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
